#ExistInterpDataSet>
| Interpretive Data: |
#ExistInterpData>Drugs covered: 9-carboxy-THC
Methodology: Liquid Chromatography-Tandem Mass Spectrometry
Positive cutoff: 5 ng/mL
The drug analyte detected in this assay, 9-carboxy THC, is a metabolite of delta-9-tetrahydrocannabinol (THC). Detection of 9-carboxy THC suggests use of, or exposure to, a product containing THC. This test cannot distinguish between prescribed or non-prescribed forms of THC, nor can it distinguish between active or passive use. The 9-carboxy THC metabolite can be detected in urine for several weeks. Normalization of results to creatinine concentration can help document elimination or suggest recent use, when specimens are collected at least one week apart.
For medical purposes only; not valid for forensic use.
*ExistInterpData>
|
*ExistInterpDataSet>
#ExistCPT>
| CPT Code(s): |
82542
|
*ExistCPT>
#ExistCrossReferences>
Cross References: |
9-Carboxy-THC (Drugs of Abuse Confirmation/Quantitation - Cannabinoids (9-carboxy-THC) - Urine), Cannabinoids (Drugs of Abuse Confirmation/Quantitation - Cannabinoids (9-carboxy-THC) - Urine), Cannabis (Drugs of Abuse Confirmation/Quantitation - Cannabinoids (9-carboxy-THC) - Urine), Dronabinol (Drugs of Abuse Confirmation/Quantitation - Cannabinoids (9-carboxy-THC) - Urine), Marijuana (Drugs of Abuse Confirmation/Quantitation - Cannabinoids (9-carboxy-THC) - Urine), Marinol (Drugs of Abuse Confirmation/Quantitation - Cannabinoids (9-carboxy-THC) - Urine), Pain Management (Drugs of Abuse Confirmation/Quantitation - Cannabinoids (9-carboxy-THC) - Urine), Pain Management, Marijuana Metabolite, Quantitative, w/ medMATCH, Urine (Drugs of Abuse Confirmation/Quantitation - Cannabinoids (9-carboxy-THC) - Urine)
, Pain Management, Marijuana Metabolite, w/Confirmation w/medMATCH, Urine (Drugs of Abuse Confirmation/Quantitation - Cannabinoids (9-carboxy-THC) - Urine)
, THC (Drugs of Abuse Confirmation/Quantitation - Cannabinoids (9-carboxy-THC) - Urine) |
*ExistCrossReferences>
|